يرجى استخدام متصفح الكمبيوتر الشخصي للوصول إلى التسجيل - تداول السعودية
حسنًا
U.S. RESEARCH ROUNDUP-Incyte, ServiceNow, Spire Global
Spire Global, Inc. Class A +4.58%
VSE Corporation +2.08%
سيرفس ناو +0.60%
فيرتكس للأدوية +0.47%
Incyte Corporation -0.56%
Spire Global, Inc. Class A SPIR | 9.37 | +4.58% |
VSE Corporation VSEC | 221.09 | +2.08% |
ServiceNow, Inc. NOW | 113.87 | +0.60% |
Vertex Pharmaceuticals Incorporated VRTX | 476.50 | +0.47% |
Incyte Corporation INCY | 97.53 | -0.56% |
Dec 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Incyte, ServiceNow and Spire Global, on Wednesday.
HIGHLIGHTS
* Incyte INCY.O: Truist Securities raises target price to $103 from $93 |
* ServiceNow NOW.N: TD Cowen adjusts PT to $250 from $1,250 to reflect 5-for-1 stock split |
* Spire Global Inc SPIR.N: Alliance Global Partners cuts to neutral from buy |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Huron Consulting Group Inc HURN.O: Benchmark raises target price to $215 from $180 |
* Incyte INCY.O: Truist Securities raises target price to $103 from $93 |
* ServiceNow NOW.N: TD Cowen adjusts PT to $250 from $1,250 to reflect 5-for-1 stock split |
* Spire Global Inc SPIR.N: Alliance Global Partners cuts to neutral from buy |
* Spire Global Inc SPIR.N: Alliance Global Partners cuts target price to $9 from $17 |
* Vertex Pharmaceuticals Inc VRTX.O: Leerink Partners raises PT to $525 from $456 |
* Vse Corp VSEC.O: Jefferies raises target price to $215 from $210 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
